STOCK TITAN

APLS (NASDAQ: APLS) holder plans Rule 144 sale of 5,928 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of the company with symbol APLS has filed a notice of proposed sale of 5,928 shares of common stock under Rule 144. The shares, to be sold through Fidelity Brokerage Services LLC on the NASDAQ, have an aggregate market value of $129,025.30, while common shares outstanding are listed as 126,525,218. The shares were acquired on 01/21/2026 through restricted stock vesting from the issuer as compensation.

The filing also lists prior sales in the last three months by Pascal Deschatelets, who sold 2,277 common shares on 01/13/2026 for gross proceeds of $50,520.25 and 909 common shares on 01/20/2026 for $17,991.75. By signing the notice, the selling person represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for APLS disclose?

It discloses a planned sale of 5,928 shares of APLS common stock under Rule 144, with an aggregate market value of $129,025.30, to be sold on the NASDAQ through Fidelity Brokerage Services LLC.

How many APLS shares are outstanding according to this filing?

The filing states that there are 126,525,218 shares of APLS common stock outstanding at the time of the notice.

How were the 5,928 APLS shares to be sold acquired?

The 5,928 APLS common shares were acquired on 01/21/2026 via restricted stock vesting from the issuer as compensation.

Who has recently sold APLS shares and in what amounts?

The filing lists Pascal Deschatelets, who sold 2,277 APLS common shares on 01/13/2026 for $50,520.25 and 909 shares on 01/20/2026 for $17,991.75 in gross proceeds.

What representation does the seller make about information on APLS?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

On which market will the APLS shares be sold and through which broker?

The proposed sale of APLS common shares is to take place on the NASDAQ through Fidelity Brokerage Services LLC.
Apellis Pharmace

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Latest SEC Filings

APLS Stock Data

2.78B
106.56M
13.68%
105.74%
16.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM